Skip to main content
Full access
LETTER
Published Online: 1 April 2009

A Possible Case of Peduncular Hallucinosis in a Patient with Parkinson’s Disease Successfully Treated With Quetiapine

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Peduncular hallucinosis was first described by Lhermitt as odd visual hallucinations stemming from lesions affecting the midbrain, pons, and thalamus. 1 We report on an elderly female with Parkinson’s disease who possibly exhibits this rare form of perceptual disturbance.

Case Report

Our patient is a 76-year-old Caucasian woman with a 3-year history of Parkinson’s disease, presenting with acute dyspnea which resulted in her hospitalization. She reported visual hallucinations of “mechanical bugs walking around the hospital” and “two people fighting” in the corner of her room. The visual hallucinations began 1 year prior to her hospitalization and were nondistressing. She had insight into the visual hallucinations. Our patient was treated with carbidopa- l -dopa until 4 months prior to admission. The patient’s mental status exam was notable for bradyphasia, psychomotor retardation, and limited range of affect. She had signs of a pill rolling tremor on her left hand. She was otherwise alert and oriented times 3 with no fluctuations in consciousness. She reports visual hallucinations in the absence of bizarre delusions or auditory hallucinations. Cognitive examination was notable for deficits in short-term recall (which improved with cues) and attention span.
An MRI scan of the brain revealed a hyper-intense focus adjacent to the right thalamus consistent with an old lacunar infarct. An EEG revealed no eliptiform discharges or significant slowing.
Our patient was treated with quetiapine for the visual hallucinations, with a noted decrease in the number of hallucinations for the remainder of the hospital stay.

Discussion

Visual hallucinations often suggest a wide range of etiologies. Hallucinations and delusions occur in up to 40% of patients with Parkinson’s disease. Visual hallucinations are typically associated as a side effect of dopamine agonists, such as carbidopa- l -dopa, in about 20% of Parkinson’s disease patients; however, our patient’s visual hallucinations persisted despite discontinuation of carbidopa- l -dopa. 2 The differential diagnosis for visual hallucinations includes neurodegenerative dementias, such as Parkinson’s dementia, postictal states, intoxications/delirium tremens, migraine headache with aura, and narcolepsy. 3
Peduncular hallucinosis is a rare form of visual hallucination characterized by intense, vividly colored, nonstereotypical visual images of people, animals, and plants that are nonthreatening to the patient. The exact mechanism for peduncular hallucinosis is unknown. One theory is that when “normal” afferent input is decreased, for example by diminished visual acuity, spontaneous cerebral activity of the visual system is disinhibited, resulting in visual hallucinations. However, given the rarity of such cases, it may be that cerebral pathology may render some elderly patients vulnerable to this disinhibited phenomena associated with pontine lesions. 4 However, according to Cubo et al., 5 visual hallucinations are more likely to occur with more severe overall Parkinson’s symptoms and longer duration of Parkinson’s disease. Our patient only had Parkinson’s disease for 3 years and was only mildly impaired by the illness. Thus, based on clinical and radiographic findings, peduncular hallucinosis was considered in the differential diagnosis of our patient’s visual hallucinations. In closing, the emergence of new-onset visual hallucinations in the elderly warrants an MRI of the brain and, although rare, peduncular hallucinosis should be considered in the differential diagnosis, especially with brain stem or thalamic infarcts.

References

1.
Leo RJ, Aherens KS: Visual hallucinations in mild dementia: a rare occurrence of Lhermitte’s hallucinosis. Psychosomatics 1999; 40:360–363
2.
Cummings JL, Miller BL: Visual hallucinations: clinical occurrence and use in differential diagnosis. West J Med 1987; 146:46–51
3.
Marsh L: Neuropsychiatric aspects of Parkinson’s disease. Psychosomatics 1999; 41:15–23
4.
Feinberg WM, Rapcsak SZ: Peduncular hallucinosis following paramedian thalamic infarction. Neurology 1989; 39:1535–1536
5.
Cubo E, González M, Aguilar A, et al: [Study of associated clinical variables and phenomenology of hallucinations in Parkinson’s.] Neurologia 2006; 21:12–18 (Spanish)

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 225a - 226
PubMed: 19622697

History

Published online: 1 April 2009
Published in print: Spring, 2009

Authors

Details

David R. Spiegel, M.D.
Victoria Angeles, M.D.
Department of Psychiatry, Eastern Virginia Medical School, Norfolk, Virginia

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share